DE69504049D1 - Neue progesteronverbindung und ihre verwendung - Google Patents

Neue progesteronverbindung und ihre verwendung

Info

Publication number
DE69504049D1
DE69504049D1 DE69504049T DE69504049T DE69504049D1 DE 69504049 D1 DE69504049 D1 DE 69504049D1 DE 69504049 T DE69504049 T DE 69504049T DE 69504049 T DE69504049 T DE 69504049T DE 69504049 D1 DE69504049 D1 DE 69504049D1
Authority
DE
Germany
Prior art keywords
progesterone compound
new progesterone
new
compound
progesterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69504049T
Other languages
English (en)
Other versions
DE69504049T2 (de
Inventor
Satoshi Hibino
Eiichi Sugino
Tetsuya Kohno
Shiho Fujimori
Hideo Nemoto
Yoshitatsu Ichihara
Yoshio Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Products Co Ltd filed Critical Meiji Milk Products Co Ltd
Publication of DE69504049D1 publication Critical patent/DE69504049D1/de
Application granted granted Critical
Publication of DE69504049T2 publication Critical patent/DE69504049T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
DE69504049T 1994-04-04 1995-04-03 Neue progesteronverbindung und ihre verwendung Expired - Fee Related DE69504049T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6624694 1994-04-04
PCT/JP1995/000642 WO1995026974A1 (fr) 1994-04-04 1995-04-03 Nouveau compose de progesterone et son utilisation

Publications (2)

Publication Number Publication Date
DE69504049D1 true DE69504049D1 (de) 1998-09-17
DE69504049T2 DE69504049T2 (de) 1999-04-15

Family

ID=13310330

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69504049T Expired - Fee Related DE69504049T2 (de) 1994-04-04 1995-04-03 Neue progesteronverbindung und ihre verwendung

Country Status (6)

Country Link
US (1) US5693629A (de)
EP (1) EP0754701B1 (de)
DE (1) DE69504049T2 (de)
DK (1) DK0754701T3 (de)
ES (1) ES2119418T3 (de)
WO (1) WO1995026974A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2316303A1 (en) 1997-12-26 1999-07-08 Masaki Nakamura Suppressing agent of angiogenesis, containing dienogest as effective ingredient
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
JP2005104862A (ja) * 2003-09-29 2005-04-21 Meiji Milk Prod Co Ltd 加齢黄斑変性治療剤
WO2007110966A1 (ja) * 2006-03-24 2007-10-04 Nihon University Ｅｓ細胞を用いた肝細胞調製法
CN101759741B (zh) * 2008-11-06 2013-01-09 天津金耀集团有限公司 一种化合物及其在制备治疗血管新生的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312692A (en) * 1959-12-22 1967-04-04 Schering Corp 16-alkylene progesterones and intermediates formed in the production thereof
US3519619A (en) * 1967-01-20 1970-07-07 Schering Corp 16-alkylidene pregnanes and process for their manufacture
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
US4198403A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
US4710495A (en) * 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
DE3400188A1 (de) * 1984-01-02 1985-07-11 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 6(alpha),16(alpha)-dimethylkortikoide
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors

Also Published As

Publication number Publication date
EP0754701A1 (de) 1997-01-22
ES2119418T3 (es) 1998-10-01
DE69504049T2 (de) 1999-04-15
EP0754701A4 (de) 1996-12-02
EP0754701B1 (de) 1998-08-12
US5693629A (en) 1997-12-02
WO1995026974A1 (fr) 1995-10-12
DK0754701T3 (da) 1999-05-17

Similar Documents

Publication Publication Date Title
DE69637691D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE69638056D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE69534265D1 (de) Chimäre zytokine und ihre verwendung
DE69720389D1 (de) Zementzusammensetzungen und ihre Verwendung
ATE285827T1 (de) Neuartige affinitatsliganden und ihre verwendung
DE69519101D1 (de) Mhc-komplexe und ihre verwendung
DE69820397D1 (de) Ätzmittel und ihre Verwendung
DE59712887D1 (de) Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel
TR199501305A2 (tr) Heterosiklik bilesikler ve bunlarin hazirlanmasi ve kullanimi
DE69602787D1 (de) Rotationsbremse und ihre Verwendung
DE69528342T2 (de) Teilchenförmige Schaumkontrollmittel und ihre Verwendung
DE69513307T2 (de) Zusammensetzung und verwendung
DE69536102D1 (de) Neue streptogramine
DE69418203D1 (de) Zementiermittel und ihre verwendung
DE69806419D1 (de) Harzzusammensetzung und ihre Verwendung
DE69620914D1 (de) Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung
DE69615714T2 (de) Phosphat-zusammensetzung und ihre verwendung
DE69332815D1 (de) Polyglyzidyl-Äthern und ihre Verwendung
DE69521174T2 (de) Anthrachinonderivate mit antitumorwirkung und ihre verwendung
DE69504049D1 (de) Neue progesteronverbindung und ihre verwendung
DE59708683D1 (de) Kupfer-Chrom-Titan-Silizium-Legierung und ihre Verwendung
DE69732095D1 (de) Ionomerzusammensetzung und ihre verwendung
DE9400779U1 (de) Wohnmobilaufbau
DE59607383D1 (de) Farbstoffmischungen und ihre Verwendung
DE59610382D1 (de) Halogenbenzimidazole und ihre verwendung als mikrobizide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee